Leptospirosis
Table of Contents
- Overview
- Epidemiology
- Pathophysiology
- Transmission and Risk Factors
- Clinical Presentation — Leptospiremic Phase
- Clinical Presentation — Immune Phase and Weil's Disease
- Diagnosis
- Treatment
- Complications
- Prevention
- References
- Connections
- Featured Videos
1. Overview
Leptospirosis is a systemic bacterial infection caused by pathogenic spirochetes of the species complex Leptospira interrogans. It is the most widespread zoonotic disease in the world, with an estimated burden exceeding one million severe cases and more than 60,000 deaths annually. The disease is most prevalent in tropical and subtropical regions, with the highest incidence in Southeast Asia, India, Brazil, and the Caribbean, where warm temperatures, flooding, and close contact between humans and reservoir animals create ideal transmission conditions.
Leptospirosis follows a characteristic biphasic course. The initial leptospiremic phase (days 1–7) features abrupt fever, severe headache, and intense myalgia — particularly in the calf muscles, which is considered pathognomonic when present. Most patients recover after this phase. In approximately 10% of cases, however, a second immune-mediated phase emerges after a brief apparent recovery, culminating in the severe syndrome known as Weil's disease, defined by the triad of jaundice, acute kidney injury, and hemorrhage.
Named variants include Canicola fever (caused by L. canicola acquired from dogs, characterized predominantly by aseptic meningitis) and Fort Bragg fever (a pretibial rash variant caused by L. autumnalis, first described in soldiers at Fort Bragg, North Carolina). Despite its global importance, leptospirosis remains a neglected tropical disease, chronically underdiagnosed and underreported.
2. Epidemiology
The global burden of leptospirosis is concentrated in low- and middle-income tropical countries. Countries reporting the highest incidence rates include India, Brazil, Sri Lanka, Thailand, the Philippines, Indonesia, and several Caribbean island nations. The WHO estimates that leptospirosis accounts for nearly 500,000 cases requiring hospitalization each year, though surveillance is poor and true incidence is substantially higher.
A defining epidemiological feature is the relationship between flooding and outbreak amplification. Heavy rains flush rodent urine from burrows into waterways and mud, dramatically expanding environmental contamination. Large outbreaks following floods have been documented repeatedly in the Philippines after typhoons, in the Brazilian state of São Paulo, and across flood-affected districts of India. Climate change, which is increasing flood frequency in many endemic regions, is projected to expand leptospirosis burden further.
Specific occupational groups carry substantially elevated risk, including rice paddy farmers, sugarcane workers, sewer and sanitation workers, abattoir workers, military personnel engaged in jungle training, veterinarians, agricultural workers, and competitive swimmers and triathletes who train in open freshwater. In the United States, leptospirosis is uncommon — roughly 100 to 200 cases are reported annually — with most cases concentrated in Hawaii and Puerto Rico, where tropical conditions persist. Cases in the continental United States frequently involve travel to endemic regions or recreational freshwater exposure.
Leptospirosis disproportionately affects impoverished urban populations in endemic countries, particularly slum communities where rodent density is high and sanitation infrastructure is poor. It qualifies formally as a neglected tropical disease under WHO criteria, receiving minimal research investment relative to its global mortality burden.
3. Pathophysiology
Leptospira interrogans are slender, obligately aerobic spirochetes measuring 0.1 µm in diameter and 6–20 µm in length with distinctive hooked ends at one or both poles. They are uniquely motile via internal periplasmic flagella (endoflagella) that wind through the periplasmic space rather than projecting externally as in other flagellated bacteria. This mechanism allows rapid corkscrew-like motility through viscous tissue matrices, facilitating tissue invasion.
The outer membrane of Leptospira contains lipopolysaccharide (LPS), but this leptospiral LPS is structurally distinct from classical gram-negative LPS and is significantly less pyrogenic than enterobacterial endotoxin. The organism's virulence is mediated by a complex of mechanisms including sphingomyelinase-like toxins, outer membrane proteins that bind host extracellular matrix components (fibronectin, collagen, laminin), and surface-exposed lipoproteins that activate toll-like receptors.
Following entry through skin abrasions, mucous membranes, or the conjunctiva, spirochetes enter the bloodstream and disseminate widely. Hepatic injury results from direct toxic effects of leptospiral membrane components on hepatocytes combined with inflammatory cytokine release; bile canalicular dysfunction produces conjugated hyperbilirubinemia. Renal injury primarily affects the proximal renal tubules — tubulointerstitial nephritis and tubular necrosis produce azotemia, hematuria, and leptospiruria; glomerular involvement is secondary. Pulmonary hemorrhage syndrome, a distinct and highly lethal complication, results from diffuse alveolar hemorrhage caused by endothelial damage and immune complex deposition — it is mechanistically different from cardiogenic pulmonary edema and does not respond to diuresis.
Systemic endothelial damage leads to capillary leak, thrombocytopenia, and hemorrhagic manifestations. The immune phase of illness, beginning around day 7–10, is triggered by antibody production against leptospiral antigens; circulating immune complexes deposit in the kidney, eye, and meninges, driving the complications that define Weil's disease. Persistent antigen in ocular tissues can provoke uveitis weeks to months after the acute illness has resolved.
4. Transmission and Risk Factors
Leptospirosis is transmitted from animal reservoir hosts to humans through direct or indirect contact with infected urine or urine-contaminated environments. Rats — particularly the black rat (Rattus rattus) and brown rat (Rattus norvegicus) — are the primary and most epidemiologically important reservoir worldwide. Infected reservoir animals typically do not develop disease; they shed leptospires continuously in urine for months to years. Other important reservoir hosts include cattle, dogs, pigs, horses, and a wide range of wildlife species.
Environmental persistence is a key factor: leptospires can survive for weeks to months in alkaline, moist soil and water. They are killed by acidic conditions, desiccation, and standard disinfectants. Flooding is the most dangerous environmental amplification event because it disperses contaminated material over wide areas and creates standing water where leptospires accumulate.
High-risk transmission scenarios include:
- Rice paddy and sugarcane farming in endemic countries — wading barefoot in flooded fields
- Sewer, drainage, and abattoir work with direct animal-waste exposure
- Freshwater recreational activities — swimming, kayaking, triathlon training in rivers or lakes
- Military jungle operations and disaster-relief work in flooded areas
- Veterinary and agricultural work with livestock or companion animals
- Pet dog exposure, particularly from dogs that roam outdoors and contact wildlife
- Post-hurricane or post-flood recovery in endemic regions
Leptospirosis is not transmitted person-to-person. Infected patients do not pose a risk to household contacts, caregivers, or healthcare workers under standard precautions.
5. Clinical Presentation — Leptospiremic Phase (Days 1–7)
The leptospiremic phase begins abruptly after an incubation period of 2 to 26 days (typically 5–14 days following exposure). The onset is sudden and dramatic, frequently leading patients to seek care within 24–48 hours of symptom development.
Cardinal features of the leptospiremic phase:
- High fever (39–40°C / 102–104°F), often with rigors and profuse sweating
- Severe headache — frontal or retro-orbital, often described as the worst headache of the patient's life
- Myalgia — intense muscle aching with particular involvement of the calf muscles and lower back. Calf myalgia so severe that patients may be unable to walk is considered pathognomonic when present
- Conjunctival suffusion — bilateral diffuse redness of the conjunctivae without discharge. This is an important distinguishing feature from viral conjunctivitis: there is no purulent or watery discharge, just intense redness from vascular engorgement. Present in 30–40% of cases
- Nausea, vomiting, and abdominal pain
- Occasional macular or maculopapular rash
During this phase, leptospires are recoverable from blood and cerebrospinal fluid. Most patients who receive appropriate antibiotic treatment during the leptospiremic phase recover fully without progressing to the second phase. Without treatment, fever typically subsides after 3–7 days, followed by a brief apparent improvement before — in susceptible individuals — the immune phase begins.
6. Clinical Presentation — Immune Phase and Weil's Disease
After the initial leptospiremic phase, approximately 90% of patients recover fully. In the remaining 10%, an apparent improvement lasting 1 to 3 days is followed by return of fever and the onset of the immune (leptospiruria) phase, driven by antibody production and immune complex deposition rather than active bacteremia.
Weil's disease — the severe icteric form of leptospirosis — is defined by its classic triad:
- Jaundice — deeply yellow sclera and skin from conjugated hyperbilirubinemia; the liver injury is primarily hepatocellular with bile canalicular dysfunction, not cholestatic obstruction
- Acute kidney injury — tubular necrosis with rising creatinine, oliguria or anuria, hematuria, and proteinuria; dialysis is required in severe cases
- Hemorrhage — driven by thrombocytopenia and endothelial capillary leak, producing petechiae, ecchymoses, epistaxis, and most critically, pulmonary hemorrhage syndrome — diffuse alveolar hemorrhage that manifests as hemoptysis, rapidly progressive respiratory failure, and ARDS with high mortality (up to 50% in some series)
Additional immune-phase manifestations include:
- Aseptic meningitis — present in up to 25% of cases; CSF shows lymphocytic pleocytosis with normal glucose
- Uveitis — the most important late complication; can appear weeks to months after apparent recovery due to persistent leptospiral antigen in ocular tissues; may be unilateral or bilateral and can cause chronic vision impairment if untreated
- Myocarditis — arrhythmias (atrial fibrillation, AV block) and cardiac dysfunction
- Canicola fever — the form caused by L. canicola (from dogs) tends to present predominantly with aseptic meningitis and milder systemic illness than serovars carried by rodents
- Fort Bragg fever — the pretibial rash variant caused by L. autumnalis; characterized by a raised erythematous rash on the pretibial (lower leg front) surface appearing in the first week
7. Diagnosis
Diagnosis rests on a combination of clinical suspicion — particularly in patients with fever, calf myalgia, and conjunctival suffusion following relevant exposure — and laboratory confirmation. Early clinical diagnosis is critical because antibiotic efficacy is greatest when treatment begins within the first week.
Direct detection methods (useful early, first 7 days):
- PCR on blood (days 1–7) or urine (from day 7 onward) is the most sensitive early test in resource-adequate settings; sensitivity is highest in the first week before antibody titers rise
- Darkfield microscopy of blood or urine is insensitive and highly operator-dependent; not recommended as a primary diagnostic tool
- Culture on EMJH (Ellinghausen-McCullough-Johnson-Harris) medium is the gold standard for organism isolation but requires 2–4 weeks and is available only in reference laboratories; not useful for acute clinical decisions
Serological methods:
- IgM ELISA (Lepto Tek Dri-Dot and similar) — antibodies detectable from day 4–5; sensitivity reaches 70–80% by day 7 and improves further with disease progression; widely used in endemic countries
- Microscopic agglutination test (MAT) — the serological gold standard; uses live cultures of reference serovars; a single titer of ≥1:800 in an endemic area with compatible illness is diagnostic; a fourfold rise between acute and convalescent titers (2–4 weeks apart) confirms infection; requires specialized reference laboratory
Characteristic laboratory findings:
- Elevated serum creatinine and BUN (acute kidney injury)
- Elevated total bilirubin, predominantly conjugated (hepatic involvement)
- Markedly elevated creatine phosphokinase (CPK) — from skeletal muscle involvement; often striking, sometimes exceeding 10,000 U/L
- Thrombocytopenia (platelet count often <100,000/µL in Weil's disease)
- Mildly elevated AST and ALT (hepatic injury is typically moderate; very high transaminases suggest an alternative diagnosis)
- Urinalysis: hematuria, pyuria, granular casts, and proteinuria from tubular injury; leptospiruria detectable from second week
- Elevated CRP and ESR; neutrophilic leukocytosis
8. Treatment
Early antibiotic therapy reduces severity and duration of illness when initiated promptly. Treatment should not be delayed while awaiting confirmatory serology in patients with a compatible clinical presentation and relevant exposure history.
Mild to moderate disease (oral therapy):
- Doxycycline 100 mg orally twice daily for 7 days — drug of choice for mild-moderate leptospirosis; also used for post-exposure chemoprophylaxis (200 mg once weekly during high-risk exposure periods)
- Amoxicillin 500 mg orally three times daily for 7 days — acceptable alternative, particularly in children and pregnant women where doxycycline is contraindicated
- Azithromycin is an alternative in penicillin-allergic patients
Severe disease / Weil's disease (intravenous therapy):
- IV Penicillin G 1.5 million units every 6 hours for 7 days — the traditional gold standard for severe leptospirosis; efficacy established by multiple randomized controlled trials
- IV Ceftriaxone 1 g once daily for 7 days — demonstrated equivalent efficacy to penicillin in controlled trials; pharmacokinetic convenience of once-daily dosing has made it increasingly preferred in clinical practice
Supportive care for severe complications:
- Acute kidney injury — careful fluid management, electrolyte monitoring; hemodialysis or continuous renal replacement therapy (CRRT) for severe AKI; early initiation of dialysis improves outcomes in Weil's disease
- Pulmonary hemorrhage/ARDS — mechanical ventilation with lung-protective strategy; treatment is primarily supportive; vasopressors for hemodynamic instability; high-dose methylprednisolone is sometimes used but evidence is limited
- Hemorrhage/DIC — platelet transfusion for severe thrombocytopenia with active bleeding; fresh frozen plasma for coagulopathy
- Uveitis (late) — topical corticosteroids and cycloplegics; systemic corticosteroids for severe cases; ophthalmology referral essential
A Jarisch-Herxheimer reaction — fever, rigors, and transient clinical worsening within 2 hours of the first antibiotic dose — can occur with leptospirosis treatment, as with other spirochetal infections. It is self-limiting and should not prompt discontinuation of antibiotics.
9. Complications
The majority of leptospirosis cases resolve fully with timely treatment. Serious complications arise predominantly in patients who develop Weil's disease or present late without antibiotic therapy.
Acute complications:
- Acute kidney injury requiring dialysis — the most common severe complication; renal function typically recovers fully with appropriate management, even after weeks of dialysis support
- Pulmonary hemorrhage syndrome / ARDS — the leading cause of death in leptospirosis; characterized by rapidly progressive respiratory failure with hemoptysis and diffuse bilateral infiltrates; case fatality rates of 30–50% in published series
- Disseminated intravascular coagulation (DIC) — contributes to hemorrhagic manifestations and organ failure
- Myocarditis and arrhythmias — atrial fibrillation, heart block, and ventricular arrhythmias; cardiac monitoring warranted in severe cases
- Hepatic failure — uncommon even with jaundice; most patients with Weil's jaundice do not progress to fulminant liver failure
Late complications:
- Uveitis — the most important long-term sequela; typically presenting as iridocyclitis (anterior uveitis) weeks to months after apparent recovery; caused by persistent leptospiral antigen in the anterior chamber; bilateral in approximately 50% of cases; recurrent episodes can lead to cataracts, glaucoma, and permanent vision loss if not managed promptly
- Chronic kidney disease — uncommon; most leptospirosis-associated AKI is fully reversible
- Neurological sequelae — rare; chronic fatigue and cognitive symptoms have been reported following severe illness
10. Prevention
Prevention requires a combination of personal protective measures, environmental control, and public health infrastructure. No universally available vaccine exists for humans, though vaccines have been deployed in some countries.
Personal protection:
- Wear rubber boots, gloves, and protective clothing when working in potentially contaminated environments (agriculture, sewer work, flood cleanup)
- Avoid swimming or wading in rivers, lakes, or floodwaters in endemic areas, particularly after heavy rains
- Cover skin abrasions before potential water exposure
- Wash hands and exposed skin with soap and water after animal contact or outdoor activity in endemic areas
Chemoprophylaxis:
- Doxycycline 200 mg once weekly for the duration of high-risk exposure is recommended for military personnel, disaster relief workers, and flood responders in endemic areas; its effectiveness was demonstrated in trials conducted in the Philippines and with US military personnel
- Post-exposure prophylaxis (single 200 mg dose) may be offered after a defined high-risk event
Vaccines:
- Human vaccines are available and deployed in Cuba and China, providing protection against dominant local serovars; they are not approved in the United States or most Western countries
- Veterinary vaccines for cattle, pigs, and dogs reduce leptospirosis in livestock and are recommended for working dogs; vaccination of pet dogs reduces the risk of human exposure from canine shedding
Environmental and public health measures:
- Rodent control programs in agricultural and urban settings
- Sanitation infrastructure improvements, particularly in informal urban settlements
- Post-flood public health messaging about exposure avoidance and symptom recognition
- Prophylactic antibiotic distribution to flood-affected communities in high-incidence endemic areas
- Surveillance systems to detect outbreaks rapidly and guide responses
11. References
- Bharti AR, Nally JE, Ricaldi JN, et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis. 2003;3(12):757–771. PMID 14652202
- Levett PN. Leptospirosis. Clin Microbiol Rev. 2001;14(2):296–326. PMID 11292640
- Victoriano AF, Smythe LD, Gloriani-Barzaga N, et al. Leptospirosis in the Asia Pacific region. BMC Infect Dis. 2009;9:147. PMID 19732423
- Hartskeerl RA, Collares-Pereira M, Ellis WA. Emergence, control and re-emerging leptospirosis: dynamics of infection in the changing world. Curr Opin Infect Dis. 2011;24(5):484–489. PMID 21799414
- Lau CL, Smythe LD, Craig SB, Weinstein P. Climate change, flooding, urbanisation and leptospirosis: fuelling the fire? Ann N Y Acad Sci. 2010;1230:26–34. PMID 22150072
- Rajapakse S, Rodrigo C, Balaji K, Fernando SD. Treatment of leptospirosis: current evidence and gaps. J Antimicrob Chemother. 2011;66(4):733–742. PMID 21393206
- Daher EF, Abreu KL, da Silva Júnior GB. Leptospirosis-associated acute kidney injury. Am J Trop Med Hyg. 2010;82(2):201–207. PMID 20134004
- Marotto PC, Nascimento CM, Eluf-Neto J, et al. Acute lung injury in leptospirosis: clinical and laboratory features, outcome, and factors associated with mortality. Clin Infect Dis. 1999;28(2):268–273. PMID 10064238
- Costa F, Hagan JE, Calcagno J, et al. Global morbidity and mortality of leptospirosis: a systematic review. PLoS Negl Trop Dis. 2015;9(1):e0003898. PMID 25629176
- Trivedi SV, Vasava AH, Bhatia LC, Patel TC, Patel NK, Patel NT. Cyclophosphamide in pulmonary alveolar haemorrhage due to leptospirosis. J Postgrad Med. 2010;56(3):179–184. PMID 20739759
- Panaphut T, Domrongkitchaiporn S, Vibhagool A, Thinkamrop B, Susaengrat W. Ceftriaxone compared with sodium penicillin G for treatment of severe leptospirosis. Clin Infect Dis. 2003;36(12):1507–1513. PMID 12802748
- Haake DA, Levett PN. Leptospirosis in humans. Curr Top Microbiol Immunol. 2015;387:65–97. PMID 25388133
12. Connections
- Infectious Disease
- Rocky Mountain Spotted Fever
- Ehrlichiosis
- Brucellosis
- Q Fever
- Dengue Fever
- Acute Kidney Injury